Overall, these data indicated that ductal carcinomas with high CCR2 expression were associated with increased invasiveness and increased expression of CCL2, phospho-SMAD3 and phospho-p42/44MAPK. The gene discussed is SMAD3; the disease is breast ductal adenocarcinoma.